Literature DB >> 21720215

From growing to secreting: new roles for mTOR in aging cells.

Giovambattista Pani1.   

Abstract

Deregulation of the nutrient sensitive mTOR signaling pathway has been recently involved in several age-related diseases, and pharmacological blockade of mTOR extends longevity in model organisms and in mice. Mechanistic studies in vitro have shed light on the role of mTOR-dependent growth signals in promoting senescence and exhaustion of quiescent stem cells, thus linking excess nutrients to tissue ageing. Novel findings add complexity to this theoretical framework, revealing that mTOR cooperates with autophagy to promote the "secretory phenotype" of senescent cells and the release of factors known to contribute to defective renewal and dysfunction of aging tissues. Thus, both cell autonomous and cell non-autonomous mechanisms link unchecked mTOR activity to cell senescence and by extension to the aging process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720215     DOI: 10.4161/cc.10.15.16886

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  27 in total

1.  Rat retinal transcriptome: effects of aging and AMD-like retinopathy.

Authors:  Oyuna S Kozhevnikova; Elena E Korbolina; Nikita I Ershov; Natalia G Kolosova
Journal:  Cell Cycle       Date:  2013-05-06       Impact factor: 4.534

2.  Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice.

Authors:  Graham Dominick; Darlene E Berryman; Edward O List; John J Kopchick; Xinna Li; Richard A Miller; Gonzalo G Garcia
Journal:  Endocrinology       Date:  2014-12-02       Impact factor: 4.736

3.  RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.

Authors:  Xiaodong Mu; Ying Tang; Koji Takayama; Wanqun Chen; Aiping Lu; Bing Wang; Kurt Weiss; Johnny Huard
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

4.  Hypoxia and gerosuppression: the mTOR saga continues.

Authors:  Olga V Leontieva; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2012-09-17       Impact factor: 4.534

5.  Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.

Authors:  Olga V Leontieva; Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

6.  Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation.

Authors:  Behdad Afzali; Francis C Edozie; Henrieta Fazekasova; Cristiano Scottà; Peter J Mitchell; James B Canavan; Shahram Y Kordasti; Prabhjoat S Chana; Richard Ellis; Graham M Lord; Susan John; Rachel Hilton; Robert I Lechler; Giovanna Lombardi
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-11       Impact factor: 8.237

Review 7.  Caloric restriction: is mammalian life extension linked to p53?

Authors:  Paola Tucci
Journal:  Aging (Albany NY)       Date:  2012-08       Impact factor: 5.682

Review 8.  Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes.

Authors:  Albert E Berman; Olga V Leontieva; Venkatesh Natarajan; James A McCubrey; Zoya N Demidenko; Mikhail A Nikiforov
Journal:  Oncotarget       Date:  2012-12

Review 9.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09

10.  Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging.

Authors:  Olga V Leontieva; Geraldine M Paszkiewicz; Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2012-12       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.